Rockefeller Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-76,798
| Closed | -$376K | – | 1660 |
|
|
2023
Q4 | $376K | Sell |
76,798
-43,615
| -36% | -$214K | ﹤0.01% | 1414 |
|
|
2023
Q3 | $656K | Sell |
120,413
-32,668
| -21% | -$178K | ﹤0.01% | 1229 |
|
|
2023
Q2 | $964K | Sell |
153,081
-11,873
| -7% | -$74.8K | ﹤0.01% | 1101 |
|
|
2023
Q1 | $1.46M | Sell |
164,954
-1,610
| -1% | -$14.2K | 0.01% | 933 |
|
|
2022
Q4 | $1.27M | Sell |
166,564
-10,549
| -6% | -$80.5K | 0.01% | 918 |
|
|
2022
Q3 | $1.26M | Sell |
177,113
-10,748
| -6% | -$76.5K | 0.01% | 930 |
|
|
2022
Q2 | $1.52M | Sell |
187,861
-39
| -0% | -$315 | 0.01% | 849 |
|
|
2022
Q1 | $2.61M | Buy |
187,900
+22,532
| +14% | +$313K | 0.01% | 713 |
|
|
2021
Q4 | $4.64M | Buy |
165,368
+33,527
| +25% | +$941K | 0.02% | 564 |
|
|
2021
Q3 | $4.48M | Buy |
131,841
+3,727
| +3% | +$127K | 0.02% | 505 |
|
|
2021
Q2 | $5.23M | Sell |
128,114
-551,449
| -81% | -$22.5M | 0.03% | 442 |
|
|
2021
Q1 | $27.4M | Buy |
679,563
+638,841
| +1,569% | +$25.7M | 0.19% | 130 |
|
|
2020
Q4 | $2.41M | Buy |
40,722
+17,562
| +76% | +$1.04M | 0.02% | 482 |
|
|
2020
Q3 | $1.13M | Buy |
23,160
+14,520
| +168% | +$706K | 0.01% | 570 |
|
|
2020
Q2 | $418K | Buy |
8,640
+4,800
| +125% | +$232K | ﹤0.01% | 766 |
|
|
2020
Q1 | $107K | Buy |
3,840
+3,248
| +549% | +$90.5K | ﹤0.01% | 995 |
|
|
2019
Q4 | $18K | Sell |
592
-383
| -39% | -$11.6K | ﹤0.01% | 1422 |
|
|
2019
Q3 | $30K | Buy |
+975
| New | +$30K | ﹤0.01% | 1109 |
|